Download PDFJanuary 2022
Market Update: Healthcare & IT Consulting Q4 2021
As 2021 came to a close, M&A activity in the broader Healthcare IT & Consulting industry remained strong on the back of growing market tailwinds that are expected to continue into 2022 and beyond. Due to the COVID 19 pandemic, all companies within the Healthcare ecosystem were challenged to embrace digital and offer flexibility to their customers.
One trend within this ecosystem that saw rapid acceleration during 2021 was the adoption of technology-enabled services serving Pharmaceutical and Life Science Companies. As these historically highly-regulated verticals began accepting technologies such as AI, M&L, and Data Science, there has become a market opportunity for companies to assist large and small Pharma companies alike harnessing the power of digital transformation.
As Pharma & Life Science firms continue evolving through this digital revolution, the need for Digital Service Providers will likely continue to grow. See our “Sector Snapshot” for a deep dive into this topic, its development during 2021, and expectations for future growth into 2022.
7MA has completed and is currently marketing numerous M&A opportunities for companies operating in the Healthcare IT & Consulting ecosystem, and 7MA has developed unparalleled deal expertise and knowledge of industry trends, valuation multiples, and the most active strategic and financial buyers. Please contact Ben Garber, Steve Buffington, Conor Smith, or Adam Alderfer if you would like to learn more about 7MA’s Healthcare IT & Consulting practice.
